Elypta Elypta’s liquid biopsy platform is based on the discovery that a panel of 19 metabolites - glycosaminoglycans (GAGs) - are specifically deregulated across several cancer types. Co-funded by Horizon 2020 programme of the European Union. Startup company name: Elypta AB Organization number: SE559112-1214 CEO/Owner/Business leader: Karl Ingvar Erik Bergman Location: Stockholm,Sweden Founded in: 2017